Insight

Unmet needs, uncommon commitment: The shift toward investment in rare diseases

Unmet needs, uncommon commitment: The shift toward investment in rare diseases

Join biotech leaders, emerging innovators, investors and patient advocacy group reps for a candid, interactive and enlightening discussion about rare disease drug discovery and development.

Where are they now? Cocoon Biotech planning tox studies

Where are they now? Cocoon Biotech planning tox studies


May 25, 2017

Recognition from a high profile organization like the BioPharm America™ conference has been tremendous for Cocoon,” Ailis Tweed-Kent, MD, founder and CEO of Cocoon Biotech...

Where are they now? For Virvio, it’s all about visibility

Where are they now? For Virvio, it’s all about visibility


May 25, 2017

When Virvio participated in BioPharm America™’s Startup Day pitch contest in 2016, the company had been operational less than one year. It had three employees...

partnering360®: leverage and cultivate your dealmaker network

partnering360 is the network for dealmakers in the life science industry. This global community of more than 38,000 is constantly growing, and the partnering opportunities continually updating.